Platforms, Technologies, and Ligand Binding Assays
Publications

Platforms, Technologies, and Ligand Binding Assays

Industry Publications from BioAgilytix’s Expert Scientists

Explore the extensive list of ADA publications to which BioAgilytix’s scientists have contributed:


Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.
M O’Hara, D., Theobald, V., Egan, A.C., Usansky, J., Krishna, M., TerWee, J., Maia,M., Spriggs, F., Kenney, J., Safavi, A., Keefe., J. AAPS J 2012 Jun 14; 14(2): 316-28. Epub 2012 Mar 14.
Access Here

Ligand binding assays in the 21st Century laboratory: platforms.
Spriggs, F.P., Don Zhong, Z., Safavi, A., Jani, D., Dontha, N., Kant, A., Ly, J., Brilando, L., Österlund, K., Rouleau, N., Fischer, S.K., Boissonneault, M., Ray, C. AAPS J 2012 Mar; 14(1): 113-8
Access Here

Ligand Binding Assays in the 21st Century Laboratory: Automation.
Ago B. Ahene, Chris Morrow, David Rusnak, Susan Spitz, Joel Usansky, Holger Pils, Francesca Civoli, Kinnari Pandya, Brian Sue, Daniel Leach, and John Derent. AAPS J 2012 Mar; 14(1): 142-153
Access Here

Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process.
Sheldon S. Leung, Joel Usansky, Robert Lynde, Theingi Thway, Robert Hendricks, and David Rusnak. AAPS J 2012 Mar; 14(1): 105-112
Access Here

Protein-based matrix interferences in ligand-binding assays.
Gorovits B, McNally J, Fiorotti C, Leung S. Bioanalysis. 2014 Apr;6(8):1131-40
Access Here

Speak to a Scientist







What would you like to discuss?

With whom will we be speaking?






I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.